Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
591 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04502095 | Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy | completed | Phase 4 | 89 | Roswell Park Cancer InstituteOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT06213454 | Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery | completed | Phase 4 | 82 | University of Wisconsin, MadisonOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT07569926 | Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence | recruiting | Phase 4 | 142 | Blue Earth DiagnosticsINDUSTRY | 1 | Sep 29, 2026 | clinicaltrials |
| NCT03520660 | People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents | active not recruiting | Phase 4 | 121 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT04257500 | Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS(RING-PCOS) | completed | Phase 4 | 22 | Andrea Roe, MD, MPHOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT04973007 | Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases | terminated | Phase 4 | 10 | University of Colorado, DenverOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT05201781 | A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel | recruiting | Phase 4 | 295 | Janssen Research & Development, LLCINDUSTRY | 8 | Sep 25, 2026 | clinicaltrials |
| NCT06084234 | National Liver Cancer Screening Trial(TRACER) | recruiting | Phase 4 | 5,500 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT06952660 | Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer | recruiting | Phase 4 | 100 | PfizerINDUSTRY | 2 | Sep 25, 2026 | clinicaltrials |
| NCT07609940 | Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)(POPLIN) | recruiting | Phase 4 | 30 | Regeneron PharmaceuticalsINDUSTRY | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07843134 | Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery | not yet recruiting | Phase 4 | 230 | University of MinnesotaOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT06651970 | Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure | recruiting | Phase 4 | 60 | AstraZenecaINDUSTRY | 6 | Sep 24, 2026 | clinicaltrials |
| NCT03340506 | Dabrafenib and/or Trametinib Rollover Study | recruiting | Phase 4 | 100 | Novartis PharmaceuticalsINDUSTRY | 14 | Sep 23, 2026 | clinicaltrials |
| NCT04145518 | Mechanistic Characterization of Uterine Pain(MCUP) | completed | Phase 4 | 183 | Endeavor HealthOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT05144997 | Lorlatinib Continuation Study | active not recruiting | Phase 4 | 76 | PfizerINDUSTRY | 8 | Sep 23, 2026 | clinicaltrials |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | recruiting | Phase 4 | 150 | Eli Lilly and CompanyINDUSTRY | 17 | Sep 22, 2026 | clinicaltrials |
| NCT05161195 | Roll-over Study to Allow Continued Access to Ribociclib | active not recruiting | Phase 4 | 134 | Novartis PharmaceuticalsINDUSTRY | 22 | Sep 18, 2026 | clinicaltrials |
| NCT02584933 | Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study | active not recruiting | Phase 4 | 233 | Novartis PharmaceuticalsINDUSTRY | 21 | Sep 17, 2026 | clinicaltrials |
| NCT07303816 | Statins to Prevent Cancer Associated Blood Clots(STAT-CAT) | recruiting | Phase 4 | 4,000 | Brigham and Women's HospitalOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05206331 | CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study | completed | Phase 4 | 2,089 | Margarita Louise ZuleyOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05672927 | Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | recruiting | Phase 4 | 618 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06049134 | Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy | active not recruiting | Phase 4 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05979493 | QL Block in Laparoscopic Myomectomy | recruiting | Phase 4 | 80 | Joseph Findley MDOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07770646 | A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis | not yet recruiting | Phase 4 | 40 | The University of Texas Health Science Center, HoustonOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT04016376 | Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction | completed | Phase 4 | 1,507 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07120295 | Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories | recruiting | Phase 4 | 75 | University of Colorado, DenverOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT05700903 | Contributions to Hypertension With Androgen Deprivation Therapy(ARCH) | terminated | Phase 4 | 10 | University of Colorado, DenverOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | active not recruiting | Phase 4 | 163 | Novartis PharmaceuticalsINDUSTRY | 19 | Aug 27, 2026 | clinicaltrials |
| NCT05044819 | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | active not recruiting | Phase 4 | 154 | Jazz PharmaceuticalsINDUSTRY | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07720726 | Impact of Dysport on PMFF Donor Scar | not yet recruiting | Phase 4 | 50 | Vanderbilt University Medical CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07788742 | Efficacy of Potassium-Competitive Acid Blockers in Barrett's Esophagus (PCAB BE Study) | not yet recruiting | Phase 4 | 12 | University of North Carolina, Chapel HillOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT06029907 | Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors. | completed | Phase 4 | 21 | Duke UniversityOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT01742299 | Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator | completed | Phase 4 | 155 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 18, 2026 | clinicaltrials |
| NCT05215353 | A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors | recruiting | Phase 4 | 368 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07503925 | THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health(THRIVE) | recruiting | Phase 4 | 15 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07769047 | Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors | not yet recruiting | Phase 4 | 50 | Mayo ClinicOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT06162663 | Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors | terminated | Phase 4 | 6 | Medical University of South CarolinaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07426484 | Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy | recruiting | Phase 4 | 80 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07486713 | Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies | recruiting | Phase 4 | 16 | Rigel PharmaceuticalsINDUSTRY | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07351019 | Colonoscopy Bowel Prep Comparison Among Diabetic Patients | completed | Phase 4 | 64 | Eisenhower Army Medical CenterFED | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06412120 | Study Evaluating Safety, Tolerability, and Metabolism of Niraparib | recruiting | Phase 4 | 70 | University of MiamiOTHER | 2 | Aug 5, 2026 | clinicaltrials |
| NCT07281547 | Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain | not yet recruiting | Phase 4 | 20 | Mayo ClinicOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT05170399 | Vaccine Responses in Patients With B Cell Malignancies | recruiting | Phase 4 | 350 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06457503 | A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer(TRANSPARENT) | recruiting | Phase 4 | 100 | Coherus Oncology, Inc.INDUSTRY | 2 | Jul 30, 2026 | clinicaltrials |
| NCT07059494 | Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant | recruiting | Phase 4 | 40 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT04281017 | Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients | completed | Phase 4 | 22 | University of FloridaOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT06143631 | Prescription of Letrozole for Uterine Myoma(PLUM) | recruiting | Phase 4 | 140 | University of California, San FranciscoOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07257484 | Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors | recruiting | Phase 4 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 22, 2026 | clinicaltrials |
Data updated 8 hours agoSource updated unknownsource: clinicaltrials